Immune privileges have been demonstrated for several types of quiescent stem cells (SCs) in adult mammalian organisms. Cancer stem cells (CSCs) also manifest immune privileges, which is one of the main concerns in cancer therapy. To elucidate the strength of non-pathological SCs immune privileges, we implanted bone marrow of transgenic Nestin-GFP mice under the renal capsule of non-transgenic mice immunized with enhanced green fluorescent protein (GFP). We show that Nes-GFP+ mesenchymal stem cells (MSCs) and other subpopulations of Nes-GFP+ progenitors in mouse bone marrow have strong immune privileges, since they survive for at least six weeks despite targetedly activated against them full immune system. We also demonstrate that MSCs retain their functionality after exposition to such immune pressure by successful retransplantation of the foci into the secondary non-immunized recipients. We suggest that nestin could be a marker for a wide spectrum of quiescent SCs with strong immune privileges, including CSCs.